Deutsche Bank upgraded West Pharmaceutical Services (NYSE:WST) to Buy from Hold on Friday, even after the contract drug manufacturer witnessed a ~38% drop in the previous session following a ...

Deutsche Bank upgraded West Pharmaceutical (WST) to Buy from Hold with a price target of $250, down from $275. The company’s Q4 results and a ...

Deutsche Bank’s shift to Google Cloud powers up its AI capabilities, optimising operations and slashing process times ...

In a report released today, Tom Sykes from Deutsche Bank maintained a Buy rating on Unilever (ULVR – Research Report), with a price target of ...

Deutsche Bank AG was fined €10 million ($10.3 million) by Spain’s securities regulator CNMV for selling derivatives to ...

The bank on Thursday ditched its closely watched cost target for 2025, saying it wanted to make investments in business. It now aims for a cost-to-income ratio of below 65%, compared with previous ...

Deutsche Bank reported solid Q4 results with €7.2 billion in revenue, driven by a 30% YoY jump in the investment bank. Read more about DB stock here.

Spanish supervisors said on Monday they had fined Germany's Deutsche Bank 10 million euros ($10.32 million) for infringements ...

Deutsche Bank Aktiengesellschaft's Q4 results showed an 8.6% revenue increase but a 17% drop in pre-tax profit. Click here to ...

UBS’s stock is now worth buying, after tumbling following the Swiss banking giant’s fourth-quarter earnings report, Deutsche ...

Deutsche Bank Aktiengesellschaft assumed coverage on shares of Praxis Precision Medicines (NASDAQ:PRAX – Free Report) in a research note issued to investors on Tuesday, Ratings reports. The brokerage ...